Calista Therapeutics' Grant

Calista Therapeutics raised a round of funding on May 28, 2013. Investors include MassChallenge.

Founded in 2012, Calista Therapeutics is a specialist biopharmaceutical company developing unique, small peptide treatments for the unmet clinical need in Cystic Fibrosis, Sub Arachnoid Hemorrhage and…

Articles about Calista Therapeutics' Grant: